Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China
· Delayed Price · Currency is CNY 35.92
+1.59 (4.63%)
Apr 29, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 5.26 billion as of April 29, 2026. Its market cap has increased by 27.31% in one year.
Market Cap
5.26B
Enterprise Value
3.86B
Revenue
449.50M
Ranking
n/a
PE Ratio
171.74
Stock Price
35.92
Market Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 5.26B, a decrease of -36.12%. That is a compound annual growth rate of -9.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 5.26B | -4.92% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Bioperfectus Technologies | 5.08B |
| Beijing Scitop Bio-tech | 4.95B |
| ChemPartner PharmaTech | 5.28B |
| Assure Tech (Hangzhou) | 4.75B |
| Wuhan Hvsen Biotechnology | 5.48B |
| Beijing Bohui Innovation Biotechnology Group | 4.54B |
| Kexing Biopharm | 5.67B |
| PharmaResources (Shanghai) | 5.72B |